Search - tctmd.com

Displaying 61 - 80 of 1199

Sort: Relevancy | Date

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

Surgeons Formalize Support for ESC’s Stance on Revascularization in CCS

News Daily News

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Michael O'Riordan

January 20, 2025

News Daily News

Mobile Health for Cardiac Rehab Doesn’t Aid Older Adults With CVD: RESILIENT

Caitlin E. Cox

January 15, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Yael L. Maxwell

December 05, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Advertisement

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Experts Hash Out Recommendations for Impella CP After DanGer Shock

January 2025 Dispatch for the CV Team

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Mobile Health for Cardiac Rehab Doesn’t Aid Older Adults With CVD: RESILIENT

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Top Endovascular News of 2024

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content